RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00034926.xml
Homeopathy
DOI: 10.1055/s-0044-1788663
DOI: 10.1055/s-0044-1788663
Original Research Article
Effectiveness of Eupatorium Perfoliatum 30C in Preventing Dengue Fever—A Prospective, Community-Based, Open Label, Parallel Cohort Study in Delhi, India
Funding This study was funded by the Central Council for Research in Homoeopathy, New Delhi, India.
Abstract
Objective The study was undertaken to evaluate the protective effect of Eupatorium perfoliatum (EP) 30C on the incidence of dengue fever.
Design This study was designed as a prospective, open label, parallel cohort study.
Interventions Participants were enrolled in two medicine cohort (MC) communities and one control cohort (CC) community. Participants in MC who were more than 5 years of age received four medicated globules and those aged between 1 and 5 years received two medicated globules of EP 30C once a week for 10 weeks. Participants in CC received no medical intervention. Both cohorts received information and educational material regarding dengue.
Outcome Measures The primary outcome was incidence of dengue cases based on laboratory confirmation or the clinical definition of dengue as per the case definition notified by the National Vector-Borne Disease Control Program, Government of India, during the 14 weeks of intervention and observation.
Results The analysis included 20,607 participants residing in three slums of Delhi, of which MC and CC included 15,298 and 5,309 participants respectively. The overall protective effect of EP 30C in MC against probable/laboratory-confirmed dengue was 59.59% (95% confidence interval [CI], 50.74 to 66.85, p = 0.0001). The overall protective effect of EP 30C against laboratory-confirmed dengue was 72.78% (95% CI, 54.45 to 83.74, p = 0.0001): 26 cases per 15,298 (0.13 per 1,000 person-weeks) in MC versus 33 cases per 5,309 (0.46 per 1,000 person-weeks) in CC.
Conclusion The use of EP 30C was associated with some protection against probable and laboratory-confirmed dengue.
Publikationsverlauf
Eingereicht: 07. Dezember 2023
Angenommen: 03. Juni 2024
Artikel online veröffentlicht:
24. Oktober 2024
© 2024. Faculty of Homeopathy. This article is published by Thieme.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 World Health Organization. Dengue and Severe Dengue. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue . Accessed September 13, 2023
- 2 Guzman MG, Halstead SB, Artsob H. et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8: S7-S16
- 3 Guha-Sapir D, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2005; 2: 1
- 4 Shepard DS, Undurraga EA, Betancourt-Cravioto M. et al. Approaches to refining estimates of global burden and economics of dengue. PLoS Negl Trop Dis 2014; 8: e3306
- 5 Shepard DS, Halasa YA, Tyagi BK. et al. Economic and disease burden of dengue illness in India. Am J Trop Med Hyg 2014; 91: 1235-1242
- 6 Jain S, Dixit G, Kohli V. Trend and epidemiological profile of dengue fever/dengue haemorrhagic fever in Ahmedabad City, Gujarat, India. Healthline. J Indian Associat Prevent Social Med. 2019; 10: 62-67
- 7 Kakkar M. Dengue fever is massively under-reported in India, hampering our response. BMJ 2012; 345: e8574
- 8 National Center for Vector Borne Diseases Control. Dengue/DHF situation in India. Available from: https://nvbdcp.gov.in/index4.php?lang=1&level=0&linkid=431&lid=3715 . Accessed September 13, 2023
- 9 Das S, Sarfraz A, Jaiswal N, Das P. Impediments of reporting dengue cases in India. J Infect Public Health 2017; 10: 494-498
- 10 Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis. Int J Infect Dis 2019; 84S: S68-S73
- 11 Telle O, Nikolay B, Kumar V. et al. Social and environmental risk factors for dengue in Delhi city: a retrospective study. PLoS Negl Trop Dis 2021; 15: e0009024
- 12 Van Benthem BH, Vanwambeke SO, Khantikul N. et al. Spatial patterns of and risk factors for seropositivity for dengue infection. Am J Trop Med Hyg 2005; 72: 201-208
- 13 Ahamed SF, Rosario V, Britto C. et al. Emergence of new genotypes and lineages of dengue viruses during the 2012-15 epidemics in southern India. Int J Infect Dis 2019; 84S: S34-S43
- 14 Barde PV, Shukla MK, Bharti PK, Kori BK, Jatav JK, Singh N. Co-circulation of dengue virus serotypes with chikungunya virus in Madhya Pradesh, central India. WHO South-East Asia J Public Health 2014; 3: 36-40
- 15 Rodríguez-Barraquer I, Solomon SS, Kuganantham P. et al. The hidden burden of dengue and chikungunya in Chennai, India. PLoS Negl Trop Dis 2015; 9: e0003906
- 16 Hisamuddin M, Tazeen A, Abdullah M. et al. Co-circulation of Chikungunya and dengue viruses in dengue endemic region of New Delhi, India during 2016. Epidemiol Infect 2018; 14: 1642-1653
- 17 World Health Organization. Global Strategy for Dengue Prevention and Control 2012–2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/75303/9789241504034_eng.pdf Accessed April 23, 2024
- 18 Bhatia R, Dash AP, Sunyoto T. Changing epidemiology of dengue in South-East Asia. WHO South-East Asia J Public Health 2013; 2: 23-27
- 19 Mørch K, Manoharan A, Chandy S. et al. Acute undifferentiated fever in India: a multicentre study of aetiology and diagnostic accuracy. BMC Infect Dis 2017; 17: 665
- 20 Halstead SB, Katzelnick LC, Russell PK. et al. Ethics of a partially effective dengue vaccine: lessons from the Philippines. Vaccine 2020; 38: 5572-5576
- 21 Wilder-Smith A. Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers. J Travel Med 2018; 1-3
- 22 Anantharaj A, Agrawal T, Shashi PK. et al. Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection. Commun Med (Lond) 2023; 3: 148
- 23 Planning Department, Government of NCT of Delhi. Chapter 14: Housing and Urban Development. In Government of Delhi, Economic Survey of Delhi 2022–23. 2023: 247-278 . Available from: https://delhiplanning.delhi.gov.in/sites/default/files/Planning/ch._14_housing_and_urban_development.pdf . Accessed April 21, 2024
- 24 National Center for Vector Borne Diseases Control. Message from Director. Available from: https://ncvbdc.mohfw.gov.in/index4.php?lang=1&level=0&linkid=403&lid=3680 . Accessed September 29, 2023
- 25 Daudé É, Mazumdar S, Solanki V. Widespread fear of dengue transmission but poor practices of dengue prevention: a study in the slums of Delhi, India. PLoS One 2017; 12: e0171543
- 26 Kusuma YS, Babu BV. The costs of seeking healthcare: illness, treatment seeking and out of pocket expenditures among the urban poor in Delhi, India. Health Soc Care Community 2019; 27: 1401-1420
- 27 Negro FE, Marino FV. Homeopathy in epidemics: from cholera to 1918 Spanish flu (Part 2). OBM Integr Complement Med 2021; 6: 045
- 28 Varanasi R, Nayak D. Homoeopathy in the management of infectious diseases: Different facets of its use and implications for the future. Indian J Res Homoeopathy 2020; 14: 110-121
- 29 Jacobs J. Homeopathic prevention and management of epidemic diseases. Homeopathy 2018; 10: 157-160
- 30 Mahesh S, Mahesh M, Vithoulkas G. Could homeopathy become an alternative therapy in dengue fever? An example of 10 case studies. J Med Life 2018; 11: 75-82
- 31 Nayak D, Chadha V, Jain S. et al. Effect of adjuvant homeopathy with usual care in management of thrombocytopenia due to dengue: a comparative cohort study. Homeopathy 2019; 108: 150-157
- 32 Hassan S, Tariq I, Khalid A, Karim S. Comparative clinical study on the effectiveness of homeopathic combination remedy with standard maintenance therapy for dengue fever. Trop J Pharm Res 2013; 12: 767-770
- 33 Ching S, Ramachandran V, Gew LT. et al. Complementary alternative medicine use among patients with dengue fever in the hospital setting: a cross-sectional study in Malaysia. BMC Complement Altern Med 2016; 16: 37
- 34 Nunes LAS. Contribution of homeopathy to the control of an outbreak of dengue in Macaé, Rio de Janeiro. Int J High Dilution Res 2008; 7: 186-192
- 35 Marino R. Homeopathy and collective health: the case of dengue epidemics. Int J High Dilution Res. 2008; 7: 179-185
- 36 Keawmuneewong W, Thaneerat T, Limworawan P. et al. Effects of homeopathic Eupatorium perfoliatum 200C for prevention of dengue fever at community hospital and district health promotion hospital: retrospective cohort study. Thai Journal of Health Education 2019; 42: 173-189
- 37 Bracho G, Golden I. A brief history of homeoprophylaxis in Cuba, 2004–2014. Homoeopath Links 2016; 29: 128-134
- 38 Sinha M, Chakraborty U, Kool A. et al. In-vitro antiviral action of Eupatorium perfoliatum against dengue virus infection: modulation of mTOR signaling and autophagy. J Ethnopharmacol 2022; 282: 114627
- 39 Nayak D, Bhalla R, Bhalerao R. et al. Effectiveness of Eupatorium perfoliatum 30C in prevention of dengue fever and acute febrile illness during 2017 dengue outbreak in urban slums of Delhi—a prospective, open-label, community-based, parallel cohort study. Complement Med Res 2023; 30: 471-480
- 40 Ministry of Health & Family Welfare, Government of India. Homoeopathic Pharmacopoeia of India. Vol. 1, First Ed.. New Delhi: Government of India; 1971: 121
- 41 National Center for Vector Borne Diseases Control. National Guidelines for Clinical Management of Dengue Fever. Available from: https://ncvbdc.mohfw.gov.in/WriteReadData/l892s/Dengue-National-Guidelines-2014.pdf . Accessed September 29, 2023
- 42 Sinha B, Goyal N, Kumar M. et al. Incidence of lab-confirmed dengue fever in a pediatric cohort in Delhi, India. PLoS Negl Trop Dis 2022; 16: e0010333
- 43 Thai KTD, Nishiura H, Hoang PL. et al. Age-specificity of clinical dengue during primary and secondary infections. PLoS Negl Trop Dis 2011; 5: e1180
- 44 Elsey H, Manandah S, Sah D. et al. Public health risks in urban slums: findings of the qualitative ‘Healthy Kitchens Healthy Cities’ study in Kathmandu, Nepal. PLoS One 2016; 11: e0163798
- 45 Adiga A, Chu S, Eubank S. et al. Disparities in spread and control of influenza in slums of Delhi: findings from an agent-based modelling study. BMJ Open 2018; 8: e017353
- 46 Maas M, Deters AM, Hensel A. Anti-inflammatory activity of Eupatorium perfoliatum L. extracts, eupafolin, and dimeric guaianolide via iNOS inhibitory activity and modulation of inflammation-related cytokines and chemokines. J Ethnopharmacol 2011; 137: 371-381
- 47 Maas M, da Costa F, Deters A, Schmidt T, Hensel A. Eupatorium perfoliatum L.: anti-inflammatory and anti-plasmodial activity of the dichloromethane extract and novel sesquiterpene lactones. Planta Med 2010; 76 - SL_11
- 48 Lira-Salazar G, Marines-Montiel E, Torres-Monzón J, Hernández-Hernández F, Salas-Benito JS. Effects of homeopathic medications Eupatorium perfoliatum and Arsenicum album on parasitemia of Plasmodium berghei-infected mice. Homeopathy 2006; 95: 223-228
- 49 Vikram K, Nagpal BN, Pande V. et al. An epidemiological study of dengue in Delhi, India. Acta Trop 2016; 153: 21-27
- 50 Nayak D, Nahar K, Bhalerao R. et al. Effectiveness of Arsenicum album 30C in prevention of COVID-19 in individuals residing in containment zones of Delhi—a prospective, community-based, parallel cohort study. Homeopathy 2022; 111: 261-270
- 51 Smith PG, Rodrigues LC, Fine PE. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984; 1: 87-93
- 52 World Health Organization. Cohort study to measure COVID-19 vaccine effectiveness among health workers. Available at: https://www.who.int/publications/i/item/WHO-EURO2021-2141-41896-57484 . Accessed September 11, 2023
- 53 Golden I. Large scale homeoprophylaxis: results of brief and long-term interventions. Am J Hom Med 2019; 12: 31-37